Found this on the net.In other ASX corporate news today:
One of the hottest performing anti-cancer biotechs, Race Oncology (ASX:RAC), raised $1.8m from health investor Merchant Opportunities Fund. The company says it now has sufficient resources to last the year. Despite shares being issued at a 9 per cent discount, shares spiked 6 per cent.
(https://unauthorised investment advice/news/corporate-eagle-health-pounces-on-another-coronavirus-opportunity/)
www.stock head.com.au
“To have attracted such strong support from a successful biotech institutional investor with a proven track record of picking promising early-stage life sciences companies is a significant validation of Race’s plans and future potential. We thank Merchant for their support and are now funded to progress our ‘five-path’ clinical strategy for Bisantrene,” said Peter Molloy, chief executive officer of Race.
https://*********.com.au/race-oncology-raises-1-8m-advance-five-path-strategy-cancer-drug-bisantrene/
Regards
Rossi70
Bisantrene and COVID-19 Coronavirus, page-31
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.050(3.29%) |
Mkt cap ! $274.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $72.59K | 45.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7920 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3500 | 2 |
View Market Depth
| Last trade - 12.58pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |